ABOUT GALIL
A Look at Galil
Medical
The New Vision of Precision
Galil Medical is leading a new era of minimally
invasive cryotherapy solutions that enhance
patient quality of life. Since its foundation,
Galil Medical has dedicated extensive research
toward increasing the ease of use and precision
of cryotherapy and minimally invasive procedures
in order for physicians to provide patients with
rapid recovery times and a high quality of life.
Galil Medical’s technology, adopted
originally from military applications, involves
freezing and ablating diseased tissue in a technique
referred to as cryotherapy,
also referred to as cryoablation
and cryosurgery. The core technology is based
on the Joule-Thomson effect (JT), in which compressed
gas causes significant and fast temperature changes.
Galil Medical cryotherapy systems
use compressed Argon gas to produce extremely
low temperatures. As the gas passes through the
cryoablation needle, the tip of the needle is
cooled, forming an iceball, which engulfs the
tumor and destroys the tissue. A variety of needle
types is available to sculpt a freeze zone conformed
to the tumor size and shape. Galil Medical cryosurgical
systems precisely deliver sub-zero temperatures
to target tissue with the aid of patented 17-gauge
cryoablation needles and high-resolution imaging
for the cryosurgical ablation of benign and cancerous
tumors. The integration of high resolution imaging
with ultrasound, CT, or MR enables a high level
of control for needle placement and positioning,
iceball formation in real-time and the freezing
process during minimally invasive surgery. Cryotherapy ablation has been widely
used for prostate
cancer treatment and kidney
cancer treatment. New ablation treatments
for various other tumors are being developed in
the Women’s Health and Interventional Radiology
markets.
A Focus on Innovation
A strong commitment to technological
innovation has enabled Galil Medical to develop
and manufacture the smallest diameter cryoablation
needles available in the market (1.47 mm)
while maintaining high power cryosurgery (freezing)
and thawing capabilities. In addition, the company’s
multi-point
thermal sensors (MTS) provide continuous,
real-time temperature monitoring throughout the
gland, or tumor, to verify lethal temperatures
within target tissue while controlling impact
to surrounding healthy tissue during cryosurgical
treatments.
Galil Medical, a global medical device company, was founded in 1996 by Rafael Development Corporation Ltd (RDC). R&D and manufacturing facilities are based in Yokneam, Israel, and dedicated sales offices are located in Arden Hills, Minnesota, United States and London, England. Shareholders include Thomas, McNerney & Partners, Vertical Group, Investor Growth Capital, Elron Electronic industries (NASDAQ:ELRN) and RDC Rafael Development Corporation, Ltd. |
